Thanks for clarifying vintage. The extension could possibly...

First 16 Last

Share
Profile

Follow
srood

2,765 Posts.

951

19/06/15

19:09

Post #: 15499351
Share

Originally posted by vintage ↑

shelcomm - your interpretation is incorrect.

There is a legal process going on. It commenced late in 2011, when the intervenor's sought legal standing in the assessment of Strata's license application and acceptance of several contentions.

It is still going on and probably will continue for some time yet.

The last important decision was on 23 Jan 2015, when ASLB released its Initial Decision in favour of Strata.

That Initial Decision would have become the Final Decision 120 days later (i.e. on 26 May), in the event that there was no petition of review (within following 25 days).

There was a petition of review - lodged on 17 Feb.

Both Strata and the NRC staff filed submissions opposing a review. However these requests were rejected by the Commission.

The Commission subsequently had 120 days (until 16 June) to finalise its review or to seek an extension at its own discretion, as provided in the NRC Regulations (see below). That's what it has done. It wasn't the intervenors, as you suggest. It was the Commission. Why was 120 days not enough time to review the ASLB's Initial Decision? I have no idea - but as I wrote before, it is food for thought.

Until the process is over, there is no certainty as to what may happen. The ASLB decision is highly encouraging to Strata, but there is simply no guarantee that it won't be overturned by the Commission. It is unlikely, but it could happen.

It is a threat to the project commencement timeline, simple as that. How big a threat it is, is for each to judge. The only certainty is that it is NOT a zero threat. It might only be 1% or less or it might be more. Better to be aware of it than bury one's head in the sand.

§ 2.341 Review of decisions and actions of a presiding officer.

a)(2) Within 120 days after the date of a decision or action by a presiding officer, or within 120 days after a petition for review of the decision or action has been served under paragraph (b) of this section, whichever is greater, the Commission may review the decision or action on its own motion, unless the Commission, in its discretion, extends the time for its review.

Expand

Thanks for clarifying vintage.

The extension could possibly range from anything to under staffing at the commission to a genuine need to look further. Important to keep in mind the contentions placed forward at the time didnt appear to have any real substance. Any which way its nice to know the aslb have thought as little of the contentions to this date. Bodes well for the underlying strength of pens submission.

Thanks for the research.

PEN Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

OJC

SPC to merge with Original Juice Co and Nature One Dairy

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

There are more pages in this discussion • 15 more messages in this thread...

First 16 Last

Add PEN (ASX) to my watchlist

(20min delay)
Last 9.6¢		Change 0.000(0.00%)		Mkt cap ! $305.9M

Open	High	Low	Value	Volume
9.6¢	10.5¢	9.1¢	$2.766M	27.91M

Buyers (Bids)

No.	Vol.	Price($)
2	317999	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	180000	1

View Market Depth

No.	Vol.	Price($)
2	317999	0.096
2	400000	0.095
2	110989	0.091
8	1188742	0.090
3	71235	0.089

Price($)	Vol.	No.
0.098	180000	1
0.099	300000	1
0.100	293948	4
0.105	4452526	36
0.110	4053261	39

Last trade - 16.10pm 02/10/2024 (20 minute delay)

PEN (ASX) Chart

Thanks for clarifying vintage. The extension could possibly...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for clarifying vintage. The extension could possibly...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News